Shire
SHP
Delayed London Stock Exchange - 04/25 05:35:11 pm
3820GBp
-2.8%
Prev.3930.0000
Open4080.0000
High4090.5000
Low3820.0000
Volume16 374 514
Last news
Financials
Sales 2018 15 506 M
EBIT 2018 5 855 M
R. net 2018 3 268 M
Debt 2018 14 904 M
Rend. 2018 0,69%
P/E ratio 2018 17,00
P/E ratio 2019 14,47
EV / Sales 2018 4,08x
EV / Sales 2019 3,67x
Capitalization 48 300 M
Company
Shire Plc is a biopharmaceutical company.It engaged in the research, development, licensing, manufacturing, marketing, distribution and sale of medicines to meet significant unmet patient needs.The company's products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin,...
Sector :
Pharmaceuticals - NEC
Calendar :
2018-04-26 Earnings Release
Trading Rating :
Investor Rating :
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishNeutral
Resistance3 9753 9754 852
Spread/Res.-3,9%-3,9%-21%
Spread/Supp.8,9%8,9%28%
Support3 5083 5082 981